{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:07:44Z","timestamp":1767841664958,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.vaccine.2021.09.047","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T09:43:02Z","timestamp":1635154982000},"page":"6947-6955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A phase 3 clinical trial of MINHAI PCV13 in Chinese children aged from 7\u00a0months to 5\u00a0years old"],"prefix":"10.1016","volume":"39","author":[{"given":"Qi","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-5560","authenticated-orcid":false,"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"S 02","key":"10.1016\/j.vaccine.2021.09.047_b0005","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1055\/s-0039-1691801","article-title":"Community-Acquired Pneumonia in Children: Myths and Facts","volume":"36","author":"Yun","year":"2019","journal-title":"Am J Perinatol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.047_b0010","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12325-020-01248-7","article-title":"Burden of Community-Acquired Pneumonia and Unmet Clinical Needs","volume":"37","author":"Ferreira-Coimbra","year":"2020","journal-title":"Adv Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2021.09.047_b0015","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"GBD","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.09.047_b0020","unstructured":"World Health Organization. Pneumonia. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pneumonia. (Accessed October 21, 2020)."},{"key":"10.1016\/j.vaccine.2021.09.047_b0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mimet.2017.07.015","article-title":"Current challenges in the accurate identification of Streptococcus pneumoniae and its serogroups\/serotypes in the vaccine era","volume":"141","author":"Varghese","year":"2017","journal-title":"J Microbiol Methods"},{"issue":"Supplement","key":"10.1016\/j.vaccine.2021.09.047_b0030","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/00006454-199910001-00008","article-title":"Bacterial and viral etiology of severe infection in children less than three months old in the highlands of Papua New Guinea","volume":"18","author":"Lehmann","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2021.09.047_b0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.047_b0040","doi-asserted-by":"crossref","first-page":"ofu024","DOI":"10.1093\/ofid\/ofu024","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions","volume":"1","author":"Shea","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2021.09.047_b0045","first-page":"326","article-title":"The capsule of Streptococcus pneumoniae contributes to virulence in the insect model Manduca sexta","volume":"22","author":"Roth","year":"2012","journal-title":"J Mol Microbiol Biotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.047_b0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/QCO.0000000000000536","article-title":"The evolving burden of viruses in pneumonia","volume":"32","author":"Brenner","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.09.047_b0055","first-page":"27","article-title":"Progress in prevention and treatment of streptococcal pneumonia in children","volume":"1","author":"Quanhua","year":"2013","journal-title":"J Clin Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.047_b0060","first-page":"1068","article-title":"R\u00e9sistance des pneumocoques [Resistance of pneumococcus]","volume":"44","author":"Goldstein","year":"1994","journal-title":"Rev Prat"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.09.047_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0213-005X(17)30028-9","article-title":"Actualizaci\u00f3n en la resistencia antibi\u00f3tica en Gram positivos [Update on antibiotic resistance in Gram-positive bacteria]","volume":"35","author":"Lozano","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"6","key":"10.1016\/j.vaccine.2021.09.047_b0070","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/21645515.2018.1435224","article-title":"Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis","volume":"14","author":"Chen","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"42","key":"10.1016\/j.vaccine.2021.09.047_b0075","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1016\/j.vaccine.2020.08.035","article-title":"Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study","volume":"38","author":"McCollum","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2021.09.047_b0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2213-2600(16)00052-7","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study","volume":"4","author":"McCollum","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.vaccine.2021.09.047_b0085","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/14760584.2017.1360771","article-title":"A systematic review about Streptococcus Pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed","volume":"16","author":"Lyu","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"48","key":"10.1016\/j.vaccine.2021.09.047_b0090","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.09.047_b0095","unstructured":"Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics. 2002; 17\u201323."},{"key":"10.1016\/j.vaccine.2021.09.047_b0100","unstructured":"World Health Organization. Annex 3. Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines: Replacement of WHO Technical Report Series, No. 927, Annex 2 Available at: http:\/\/www.who.int\/entity\/biologicals\/vaccines\/TRS_977_Annex_3.pdf?ua=1. Accessed October 21, 2020."},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.047_b0105","first-page":"514","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.09.047_b0110","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/CVI.00086-12","article-title":"Development of a fourfold multiplexed opsonophagocytosis assay for pneumococcal antibodies against additional serotypes and discovery of serological subtypes in Streptococcus pneumoniae serotype 20","volume":"19","author":"Burton","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2021.09.047_b0115","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2014.01.047","article-title":"Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines","volume":"32","author":"Pobre","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.047_b0120","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/pbc.25502","article-title":"13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6\u201317 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study","volume":"62","author":"De Montalembert","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.047_b0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/infdis\/170.2.461","article-title":"Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986\u20131990","volume":"170","author":"Parkinson","year":"1994","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.047_b0130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1128\/IAI.69.2.787-793.2001","article-title":"Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice","volume":"69","author":"Tuomanen","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2021.09.047_b0135","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CVI.00344-08","article-title":"Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A","volume":"16","author":"Lee","year":"2009","journal-title":"Clin Vaccine Immunol : CVI"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.047_b0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/INF.0000000000002109","article-title":"Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic","volume":"37","author":"Prymula","year":"2018","journal-title":"Pediatric Infect Dis J"},{"issue":"14","key":"10.1016\/j.vaccine.2021.09.047_b0145","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.vaccine.2015.02.005","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naive to pneumococcal vaccination","volume":"33","author":"Wysocki","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.09.047_b0150","unstructured":"Center For Drug Evaluation. Guidelines for grading standards for adverse reactions in clinical trials of prophylactic vaccines. Available at: http:\/\/www.cde.org.cn\/search.do?method=searchTitle."},{"issue":"38","key":"10.1016\/j.vaccine.2021.09.047_b0155","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/j.vaccine.2019.09.065","article-title":"Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes","volume":"38","author":"Kim","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.047_b0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/infdis\/132.1.62","article-title":"Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody","volume":"132","author":"Gwaltney","year":"1975","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.047_b0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/ijms18010105","article-title":"Pneumococcal Colonization in the Familial Context and Implications for Anti-Pneumococcal Immunization in Adults: Results from the BINOCOLO Project in Sicily","volume":"18","author":"Tramuto","year":"2017","journal-title":"Int J Mol Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:04:19Z","timestamp":1759403059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2101238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":33,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0264410X2101238X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 3 clinical trial of MINHAI PCV13 in Chinese children aged from 7\u00a0months to 5\u00a0years old","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}